about
Integration of data from omic studies with the literature-based discovery towards identification of novel treatments for neovascularization in diabetic retinopathy.Photocoagulation of human retinal pigment epithelial cells in vitro: evaluation of necrosis, apoptosis, cell migration, cell proliferation and expression of tissue repairing and cytoprotective genes.Cost-utility of ranibizumab versus aflibercept for treating Greek patients with visual impairment due to diabetic macular edema.Hypoxic retinal Muller cells promote vascular permeability by HIF-1-dependent up-regulation of angiopoietin-like 4.Intravitreal Corticosteroids in the Management of Diabetic Macular EdemaEmerging drugs for diabetic macular edema.Blood flow parameters of the central retinal and internal carotid arteries in asymmetric diabetic retinopathyEffects of Fenofibric Acid on Diabetic Macular Edema: The MacuFen study
P2860
Q30718043-0E7A912A-AC9C-4116-AD15-E07EB5928888Q34925891-77DBC19A-61AA-4AA9-9002-B194C9617918Q36796899-65F2425A-96D9-4D84-BF21-ECBF1287F99DQ37157321-E1FA86A0-041A-4145-9939-96CA9818AC59Q37287831-5D075266-54C7-4349-AA04-C99700332BC1Q38241679-70DCFE99-9A3C-4224-9610-0F4612BA201CQ41210628-F94661C8-FBB9-42BC-8457-B7130A64BEE1Q58384543-14EA966A-A7FD-4D43-BC18-219C392CDF6F
P2860
description
wetenschappelijk artikel
@nl
наукова стаття, опублікована в лютому 2012
@uk
name
Emerging pharmacotherapies for diabetic macular edema
@en
Emerging pharmacotherapies for diabetic macular edema
@nl
type
label
Emerging pharmacotherapies for diabetic macular edema
@en
Emerging pharmacotherapies for diabetic macular edema
@nl
prefLabel
Emerging pharmacotherapies for diabetic macular edema
@en
Emerging pharmacotherapies for diabetic macular edema
@nl
P2093
P2860
P356
P1476
Emerging pharmacotherapies for diabetic macular edema
@en
P2093
Golnaz Javey
Harry W Flynn
Stephen G Schwartz
P2860
P304
P356
10.1155/2012/548732
P407
P5008
P577
2012-02-26T00:00:00Z